Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older

This survey study assesses the occurrence of short-term adverse events in adults 60 years or older who received a booster dose of the BNT162B2 mRNA vaccine.

Detalles Bibliográficos
Autores principales: Auster, Oren, Finkel, Uriah, Dagan, Noa, Barda, Noam, Laufer, Alon, Balicer, Ran D., Ben-Shachar, Shay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016488/
https://www.ncbi.nlm.nih.gov/pubmed/35435973
http://dx.doi.org/10.1001/jamanetworkopen.2022.7657
_version_ 1784688538021789696
author Auster, Oren
Finkel, Uriah
Dagan, Noa
Barda, Noam
Laufer, Alon
Balicer, Ran D.
Ben-Shachar, Shay
author_facet Auster, Oren
Finkel, Uriah
Dagan, Noa
Barda, Noam
Laufer, Alon
Balicer, Ran D.
Ben-Shachar, Shay
author_sort Auster, Oren
collection PubMed
description This survey study assesses the occurrence of short-term adverse events in adults 60 years or older who received a booster dose of the BNT162B2 mRNA vaccine.
format Online
Article
Text
id pubmed-9016488
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-90164882022-05-04 Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older Auster, Oren Finkel, Uriah Dagan, Noa Barda, Noam Laufer, Alon Balicer, Ran D. Ben-Shachar, Shay JAMA Netw Open Research Letter This survey study assesses the occurrence of short-term adverse events in adults 60 years or older who received a booster dose of the BNT162B2 mRNA vaccine. American Medical Association 2022-04-18 /pmc/articles/PMC9016488/ /pubmed/35435973 http://dx.doi.org/10.1001/jamanetworkopen.2022.7657 Text en Copyright 2022 Auster O et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Auster, Oren
Finkel, Uriah
Dagan, Noa
Barda, Noam
Laufer, Alon
Balicer, Ran D.
Ben-Shachar, Shay
Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
title Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
title_full Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
title_fullStr Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
title_full_unstemmed Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
title_short Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
title_sort short-term adverse events after the third dose of the bnt162b2 mrna covid-19 vaccine in adults 60 years or older
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016488/
https://www.ncbi.nlm.nih.gov/pubmed/35435973
http://dx.doi.org/10.1001/jamanetworkopen.2022.7657
work_keys_str_mv AT austeroren shorttermadverseeventsafterthethirddoseofthebnt162b2mrnacovid19vaccineinadults60yearsorolder
AT finkeluriah shorttermadverseeventsafterthethirddoseofthebnt162b2mrnacovid19vaccineinadults60yearsorolder
AT dagannoa shorttermadverseeventsafterthethirddoseofthebnt162b2mrnacovid19vaccineinadults60yearsorolder
AT bardanoam shorttermadverseeventsafterthethirddoseofthebnt162b2mrnacovid19vaccineinadults60yearsorolder
AT lauferalon shorttermadverseeventsafterthethirddoseofthebnt162b2mrnacovid19vaccineinadults60yearsorolder
AT balicerrand shorttermadverseeventsafterthethirddoseofthebnt162b2mrnacovid19vaccineinadults60yearsorolder
AT benshacharshay shorttermadverseeventsafterthethirddoseofthebnt162b2mrnacovid19vaccineinadults60yearsorolder

Ejemplares similares